PharmaCyte Biotech Inc. (PMCB): Price and Financial Metrics
PMCB Price/Volume Stats
| Current price | $1.83 | 52-week high | $2.58 |
| Prev. close | $1.81 | 52-week low | $1.39 |
| Day low | $1.81 | Volume | 7,900 |
| Day high | $1.84 | Avg. volume | 25,084 |
| 50-day MA | $1.75 | Dividend yield | N/A |
| 200-day MA | $2.02 | Market Cap | 14.05M |
PMCB Stock Price Chart Interactive Chart >
PharmaCyte Biotech Inc. (PMCB) Company Bio
PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PMCB Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...